Abstract
Abstract
Acute kidney injury (AKI) is a multifactorial clinical syndrome associated with rapid deterioration of renal function and involves interconnected processes including oxidative stress, mitochondrial dysfunction, inflammation, endothelial injury, programmed cell death, immune dysregulation and maladaptive repair. Current management is predominantly supportive and lacks effective pharmacological strategies that simultaneously address these pathological mechanisms. Renal-targeting nanozymes have emerged as promising catalytic nanotherapeutics that combine enzyme-mimicking activity with the tunable properties of nanomaterials. This review critically examines the engineering and therapeutic potential of renal-targeting nanozymes for AKI, focusing on nanozyme platforms, catalytic properties, renal-targeting strategies, and mechanisms underlying their antioxidant,immunomodulatory, cytoprotective, and regenerative effects. Preclinical evidence from experimental AKI models is discussed with emphasis on therapeutic outcomes, comparative performance, and current limitations. Particular attention is given to challenges involving renal accumulation, biodistribution, long-term biosafety, biodegradability,reproducibility, manufacturing scalability, and regulatory requirements. Emerging strategies, including biomimetic and biodegradable nanozymes, stimulus-responsive systems, theranostic platforms, and artificial intelligence-assisted nanozyme design, are also considered. Overall, renal-targeting nanozymes represent a promising multifunctional approach for addressing the complex pathophysiology of AKI. However, standardized preclinical evaluation, scalable manufacturing, comprehensive safety assessment, appropriate regulatory frameworks, and well-designed clinical studies remain essential for translating these catalytic nanotherapeutics into clinically viable precision therapies.
Direct answer
What can I do from this paper page?
Use this page to scan "Next-Generation Renal Targeting Nanozymes for Acute Kidney Injury: Engineering Catalytic Therapeutics for Oxidative Stress, Immune Regulation, and Renal Repair" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Advanced Nanomaterials in Catalysis research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Balan2026Next,
title = {Next-Generation Renal Targeting Nanozymes for Acute Kidney Injury: Engineering Catalytic Therapeutics for Oxidative Stress, Immune Regulation, and Renal Repair},
author = {Mahalakshmi Balan and Mukundan Kavushik},
journal = {International Journal of Pharmaceutical Research and Applications},
year = {2026},
doi = {10.5281/zenodo.23801005},
url = {https://doi.org/10.5281/zenodo.23801005}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Advanced Nanomaterials in Catalysis research papers?
Follow Advanced Nanomaterials in Catalysis research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Next-Generation Renal Targeting Nanozymes for Acute Kidney Injury: Engineering Catalytic Therapeutics for Oxidative Stress, Immune Regulation, and Renal Repair. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app